Effectiveness of second-generation antipsychotics: a naturalistic, randomized comparison of olanzapine, quetiapine, risperidone, and ziprasidone

Johnsen, Erik; A.^Kroken, Rune; Wentzel-Larsen, Tore; A.^Jørgensen, Hugo
January 2010
BMC Psychiatry;2010, Vol. 10, p26
Academic Journal
Background: No clear recommendations exist regarding which antipsychotic drug should be prescribed first for a patient suffering from psychosis. The primary aims of this naturalistic study were to assess the head-to-head effectiveness of first-line second-generation antipsychotics with regards to time until drug discontinuation, duration of index admission, time until readmission, change of psychopathology scores and tolerability outcomes. Methods: Patients = 18 years of age admitted to the emergency ward for symptoms of psychosis were consecutively randomized to risperidone (n = 53), olanzapine (n = 52), quetiapine (n = 50), or ziprasidone (n = 58), and followed for up to 2 years. Results: A total of 213 patients were included, of which 68% were males. The sample represented a diverse population suffering from psychosis. At admittance the mean Positive and Negative Syndrome Scale (PANSS) total score was 74 points and 44% were antipsychotic drug naïve. The primary intention-to-treat analyses revealed no substantial differences between the drugs regarding the times until discontinuation of initial drug, until discharge from index admission, or until readmission. Quetiapine was superior to risperidone and olanzapine in reducing the PANSS total score and the positive subscore. Quetiapine was superior to the other drugs in decreasing the PANSS general psychopathology subscore; in decreasing the Clinical Global Impression - Severity of Illness scale score (CGI-S); and in increasing the Global Assessment of Functioning - Split version, Functions scale score (GAF-F). Ziprasidone was superior to risperidone in decreasing the PANSS positive symptoms subscore and the CGI-S score, and in increasing the GAF-F score. The drugs performed equally with regards to most tolerability outcomes except a higher increase of hip-circumference per day for olanzapine compared to risperidone, and more galactorrhoea for risperidone compared to the other groups. Conclusions: Quetiapine appears to be a good starting drug candidate in this sample of patients admitted to hospital for symptoms of psychosis. Trial Registration: ClinicalTrials.gov ID; URL: http://www.clinicaltrials.gov/: NCT00932529.


Related Articles

  • Antipsychotic Drug Use With Kids is Climbing, Study Finds. Carey, Benedict // Behavior Analysis Digest;Summer2006, Vol. 18 Issue 2, p5 

    The article reports that from 1995 to 2002, there had been a five-fold increase in the use of antipsychotic drugs in treating children and adolescents for problems like aggression and mood swings. The survey was based on physician visits where antipsychotic medication was prescribed. The visits...

  • "Continuous" Thioproperazine: A Controlled Trial in Chronic Schizophrenia. MacLeod, E. C.; Moffat, J. // British Journal of Psychiatry;Jul63, Vol. 109 Issue 461, p531 

    The article investigates the use of thioproperazine, a phenothiazine derivative which readily produces extra-pyramidal disturbances, for chronic schizophrenics. Several investigators have reported impressive results with this drug in a variety of mentally ill patients, including chronic...

  • Patterns of psychotropic drug use in a Spanish rural community. Vázquez-Barquero, J. L.; Diez Manrique, J. F.; Peña, C.; Arenal Gonzalez, A.; Cuesta, M. J.; Artal, J. A.; Vázquez-Barquero, J L; Peña, C // British Journal of Psychiatry;Nov89, Vol. 155, p633 

    Psychotropic drug use was investigated using a two-stage survey of a random sample of persons aged 17 and over from a rural Spanish community. It was found that 6.9%, 11.8% and 25.1% of the population were consuming psychotropic, analgesic and somatic medicines respectively. Women presented a...

  • Persistence of extra-pyramidal disorders and psychiatric relapse after withdrawal of long-term phenothiazine therapy. Hershon, H. I.; Kennedy, P. F.; McGuire, R. J. // British Journal of Psychiatry;Jan72, Vol. 120 Issue 554, p41 

    The article presents a study on the persistence of extra-pyramidal disorders and psychiatric relapse after withdrawal of long-term phenothiazine therapy. In this study, sixty-two chronic schizophrenics in hospital were studied, about 32 male and 30 female patients and they had all been on...

  • Training in cultural competence.  // CPJ: Counselling & Psychotherapy Journal;Jun2004, Vol. 15 Issue 5, p21 

    40,000 mental health workers of Great Britain's National Health Service, are to undergo a national retraining programme to root out the racist attitudes that have undermined the treatment of black and ethnic minorities. The British Government's black and ethnic minority steering group made this...

  • Parental attitudes and opinions on the use of psychotropic medication in mental disorders of childhood. Lazaratou, Helen; Anagnostopoulos, Dimitris C.; Alevizos, Elias V.; Haviara, Fotini; Ploumpidis, Dimitris N. // Annals of General Psychiatry;2007, Vol. 6, p32 

    Background: The limited number of systematic, controlled studies that assess the safety and efficacy of psychotropic medications for children reinforce the hesitation and reluctance of parents to administer such medications. The aim of this study was to investigate the attitudes of parents of...

  • Drugs and "moral treatment". Hordern, Anthony; Hamilton, Max; HORDERN, A; HAMILTON, M // British Journal of Psychiatry;Jul63, Vol. 109 Issue 461, p500 

    The article investigates the introduction of neuroleptic drugs into large overcrowded mental hospitals which has been accompanied by a striking improvement in their atmospheres that have become more therapeutic and less custodial. Accordingly, it has become possible, often for the first time, to...

  • Overinclusive thought disorder in chronic schizophrenics and its response to 'proketazine'. Payne, R. W.; Friedlander, D.; Laverty, S. G.; Haden, P. // British Journal of Psychiatry;Jul63, Vol. 109 Issue 461, p523 

    The article investigates the overinclusive thought disorder in chronic schizophrenics and its response to proketazine. The findings suggest that contrary to expectation, overinclusive thinking does not seem to be responsible for the intellectual deterioration shown by a chronic schizophrenic...

  • Pharmacogenetic and Pharmacogenomic Research in Psychiatry: Current Advances and Clinical Applications. Arranz, Maria J.; Mancama, Dalu T.; Kerwin, Robert W. // Current Pharmacogenomics;Sep2003, Vol. 1 Issue 3, p151 

    After more than 50 years of investigations, pharmacogenetic efforts have crystallized in several findings relating genetically determined pharmacokinetic and pharmacodynamic factors to treatment response. Metabolic enzymes and neurotransmitter proteins contain genetic polymorphisms that alter...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics